Healthcare Equipment and Supplies
Company Overview of Magnisense SE
Magnisense SE, a biotech company, designs, develops, and commercializes proprietary diagnostic tests for cardio-vascular diseases that be used directly by emergency physicians, reanimation specialists, cardiologists, and other physicians. It offers MIAtek cardio-vascular emergency diagnostics that consists of a mobile device and consumables, which can be used by medical practitioners to diagnose cardio-vascular events in emergency situations by measuring cardiac bio-markers in patients' blood from any location; MIAtek readers; and consumables and the signal processing software. The company was founded in 2003 and is based in Paris, France.
140 rue du Faubourg Saint Honoré
Founded in 2003
33 1 45 62 80 00
33 1 45 62 80 01
Key Executives for Magnisense SE
Similar Private Companies By Industry
|Abbott Spine S.A.||Europe|
|ABC Biokits S.A.S.||Europe|
|Acime Frame Sarl||Europe|
|Acoustique Surdité Wernert SAS||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Magnisense SE, please visit www.magnisense.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.